Tag: melphalan
Delcath Systems announces new drug application resubmission for Hepzato Kit
Delcath Systems has announced it has submitted a new drug application (NDA) resubmission to the US Food and Drug Administration (FDA) for the Hepzato...
Percutaneous melphalan perfusion can induce significant responses in uveal liver metastases
Percutaneous hepatic perfusion with melphalan for the treatment of metastatic uveal melanoma (mUM) offers a hepatic response rate of 66.7% and good progression-free survival...
